The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading

Beck, Roy W., Connor, Crystal G., Mullen, Deborah M., Wesley, David M., Bergenstal, Richard M.·2017·Diabetes Care
DOI 10.2337/dc17-0636

Cited by (478)

Items 401–478 of 478

  1. I rely more on self-monitoring of blood glucose than HbA1c to assess diabetes control. Do you?
    Kanika Tyagi · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  2. ISPAD Clinical Practice Consensus Guidelines 2018. Chapter 8. Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes
    Prepared by N. B. Zelinska · 2020 · Ukrainian Journal of Pediatric Endocrinology
  3. Identifying Clinical Phenotypes of Type 1 Diabetes for the Co-Optimization of Weight and Glycemic Control
    Anna R. Kahkoska · 2020 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  4. New Trends: Time in Range and the Use of Continuous Glucose Monitoring Devices on Glycemic Control
    Karyna Lucena Valença De Souza, Marcela Mascarenhas Braga Rassi, Diana Aristótelis Rocha de Sá, Renata Maksoud Bussuan, Luciana Corrêa de Souza Rodrigues, Alberto Krayyem Arbex · 2021 · European Journal of Medical and Health Sciences
  5. Methoden der Stoffwechselkontrolle – HbA1c versus „time in range“
    Guido Freckmann, Sina Buck, Delia Waldenmaier, Cornelia Haug · 2021 · Der Diabetologe
  6. «Your glycemic control is optimal... on average»: HbA1c pitfalls in glucose monitoring of patients with diabetes
    Nino Cristiano Chilelli · 2017 · The Journal of AMD
  7. Does HbA1c Remain the Most Important Therapeutic Target in Outpatient Management of Diabetes?
    Kristen M. Gonzales, Steve Smith · 2021 · Wiley eBooks
  8. The Association of Exercise Blood Glucose Levels and Post-Exercise Hypoglycemia in Adults with Type 1 Diabetes
    Heather Hinz · 2020 · ERA: Education and Research Archive (University of Alberta)
  9. Désordres glycémiques
    2019 · Elsevier eBooks
  10. Conclusions
    Valentino Cherubini · 2020 · Springer eBooks
  11. A New Term for Estimating HbA1c by Continuous Glucose Monitoring: Glucose Management Indicator (GMI)
    坤 胡 · 2021 · Advances in Clinical Medicine
  12. Time in range: new parameter to evaluate blood glucose control
    Milan Flekač · 2022 · Vnitřní lékařství
  13. Session One: Basal Insulins: Still Innovating After All These Years
    Lisa Michel · 2017 · EMJ Diabetes
  14. Todo lo que usted quiso saber sobre la monitorización de la glucosa y nunca se atrevió a preguntar
    José Miguel Borrachero Guijarro, Ana María Cebrián Cuenca · 2022 · Diabetes práctica
  15. Glucose Monitoring Systems - general rules of use and chances in therapy of type 1 diabetes
    Michał Garstka, Anna GADOMSKA, Justyna Kurek, Rafał GORZYŃSKI, Hanna DOMINIK, Zuzanna Czudy, Wojciech PAWĘSKA, Justyna MOLCZYK-SIEŃCZAK, Jan RADWAŃSKI, Marika POLATOWSKA · 2023 · Journal of Education Health and Sport
  16. Real-time continuous glucose monitoring systems in patients with type 1 diabetes. Expert group report
    Dorota Zozulińska‐Ziółkiewicz, Maciej Tadeusz Malecki, Leszek Czupryniak, Przemysława A. Jarosz-Chobot, Tomasz Klupa, Małgorzata Myśliwiec, Agnieszka Szadkowska, Agnieszka Szypowska, Andrzej Gawrecki, Beata Mianowska et al. · 2021 · Current Topics in Diabetes
  17. The Effect of Insulin Degludec Versus Insulin Glargine U100 on Glucose Metrics Recorded During Continuous Glucose Monitoring in People With Type 1 Diabetes and Recurrent Nocturnal Severe Hypoglycemia
    Julie Maria Bøggild Brøsen, Rikke Mette Agesen, Amra Ciric Alibegovic, Henrik Ullits Andersen, Henning Beck‐Nielsen, Peter Gustenhoff, Troels Krarup Hansen, Christoffer Hedetoft, Tonny Joran Jensen, Claus Bogh Juhl et al. · 2023 · Journal of Diabetes Science and Technology
  18. Do not report estimated average glucose (eAG) from HbA1c: Evidence is emerging
    Yu Chen · 2023 · Clinical Biochemistry
  19. Haemoglobin glycation index (HGI) as a marker of individual glycation in diabetes
    Martin Pehr, Jan Škrha · 2023 · Vnitřní lékařství
  20. Estimating Glycemia from HbA1c and CGM: Analysis of Accuracy and Sources of Discrepancy
    Veronica Tozzo, Matthew T. Genco, Shammah O. Omololu, Christopher Mow, Hasmukh R. Patel, Chhaya H. Patel, Samantha N. Ho, Ngoc Thi Dang Lam, Batoul Abdulsater, Nikita Patel et al. · 2024
  21. Bibliometric Insight into Continuous Glucose Monitoring in Diabetes Glycemic Control: Research Structure and Hotspots Evolution
    Duo Zhang, Yaqin Yang, Jiaqi Zhang, Junhui Chen, Lihua Huang, Lei Zhang, Xusheng Liu · 2024 · SSRN Electronic Journal
  22. Benefícios do monitoramento contínuo da glicose na prevenção de complicações vasculares em pacientes com DM1
    Vanessa Farias Lopes, Bárbara Borges Ferreira, Bruna Aranha Henrique, Camila Martins Palmeira de Oliveira, Isabella Lugon-Moulin Maraboti, Raquel Dália Costa da Silva Paiva, Isabella Pêgo Miranda Netto · 2024 · Brazilian Journal of Health Review
  23. Prevalence of poor glycemic control and the monitoring utility of glycated albumin among diabetic patients attending clinic in tertiary hospitals in Dodoma, Tanzania: A cross-sectional study protocol
    George Gabriel Mkumbi, Matobogolo Boaz · 2024 · PLoS ONE
  24. Technologies for Diabetes, volume II
    2024 · Frontiers research topics
  25. Intermittently scanned continuous glucose monitoring (isCGM) in hospitalized elderly patients
    Darina Matvejeva, Martina Nováková, Pavlína Piťhová, Lucie Tománková, Vladimíra Kotvová, Daniela Polanecká, Milan Kvapil · 2024 · Vnitřní lékařství
  26. ҮЗДІКСІЗ ГЛИКЕМИЯЛЫҚ МОНИТОРИНГ – ДИАБЕТОЛОГИЯДАҒЫ ЖАҢА ТЕХНОЛОГИЯЛАР (әдеби шолу)
    Indira Kaibagarova, Н М Мавлюдова, Нургалиева Ж.Ж., А. К. Овсянникова, Marina Kalzhanova · 2024 · Farmaciâ Kazahstana
  27. The Association Between Time in Range %, Measured by Continuous Glucose Monitoring (CGM) and Physical Health Agility Status Indices Amongst Older People with T2D: A Cross-Sectional Study
    Yamit Basson-Shleymovich, Tal Yahalom-Peri, Michal Azmon, Tali Cukierman‐Yaffe · 2024 · Journal of Clinical Medicine
  28. Glycemic Matrix and Segmentation: A New Metabolic Visualization and Analysis Tool
    Alberto Conde Mellado, Nere Arroniz, Leire Francés · 2024 · Journal of Biomedical Research & Environmental Sciences
  29. Impacto del inicio de la monitorización flash de glucosa en pacientes adultos con diabetes tipo 1
    Rebeca Jiménez Sahagún · 2024 · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid)
  30. Associação entre fatores relacionados à alimentação e ao tratamento com o controle glicêmico e o estado nutricional de pacientes com diabetes mellitus tipo 1 usuários de sistema de infusão contínua de insulina
    Renata Cristina Machado Mendes, Natasha Vasconcelos Albuquerque, Renan Magalhães Montenegro, Maria Yasmin Paz Teixeira Martins, Carolina Maria Teixeira dos Santos Porto, A Nunes, Carla Soraya Costa Maia, Samila Torquato Araújo · 2022 · Nutrición clínica y dietética hospitalaria/Nutrición clínica, dietética hospitalaria
  31. Glycemic Goals and Assessment of Glycemia
    2022 · American Diabetes Association eBooks
  32. Pourquoi la variabilité glycémique est-elle si importante dans le risque d’hypoglycémie iatrogène : de la théorie à la pratique
    L. Monnier, C Colette, Éric Renard, Pierre‐Yves Benhamou · 2025 · Médecine des Maladies Métaboliques
  33. Tecnologia no cuidado de pacientes com Diabetes tipo 1: a trajetória na Secretaria de Saúde do Distrito Federal
    Betyna Saldanha Corbal, Rafaela Flavia da Silva Puzic, Eliziane Brandão Leite, Érica Tatiane da Silva, Manuela Costa Melo, Michele Delarmelina Reis Borba, Camille Moreira Baptista da Silva · 2025 · Caderno Pedagógico
  34. Research Progress on the Relationship between Time within the Target Range of Glucose and Diabetes-Related Complications
    来来 石 · 2025 · Advances in Clinical Medicine
  35. Value of continuous glucose monitoring in children and adolescents with type 1 diabetes mellitus
    Dina A.H. Hegazy, Adel Ali Erfan, Wesam Salah Ibrahim, Sara I.El Shall · 2025 · Alexandria Journal of Pediatrics
  36. Validation of a predictive calculator for optimal glycemic control and time-in-tight-range following CGM sensor placement in type 1 diabetes and pancreatic diabetes: a prospective study
    Fernando Sebastián‐Valles, Juan Javier López-Hidalgo, Silvia Cañas Sierra, Víctor Navas-Moreno, José Alfonso Arranz Martín, Miguel Antonio Sampedro-Nuñez, Mónica Marazuela · 2025 · Endocrine
  37. Time in range and serum cystatin C as predictors of diabetic kidney disease in patients with type 2 diabetes
    LiangJun He, Jing Chen, WeiHong Chen, XinRu Shen · 2025 · Journal of Laboratory Medicine
  38. Prevalence of autoimmune comorbidities and association with glycemic control by CGM-derived parameters in type 1 diabetes
    Lopes, Ana Margarida Rebelo · 2025 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  39. Additional file 1 of Impact of socioeconomic status on chronic control and complications of type 1 diabetes mellitus in users of glucose flash systems: a follow-up study
    Fernando Sebastián‐Valles, Julia Martínez Alfonso, Arranz Martin, Jose Alfonso, Jessica Jiménez‐Díaz, Iñigo Hernando Alday, Víctor Navas-Moreno, Teresa Armenta Joya, Maria del Mar Fandiño García, Gisela Liz Román Gómez, Jon Garai Hierro et al. · 2024 · Figshare
  40. Additional file 1 of Association between hemoglobin within the normal range and hemoglobin A1c among Chinese non-diabetes adults
    Lai, Yi, Lin, Zhihong, Zhu, Zhongxin · 2021 · Figshare
  41. Additional file 1 of Age-specific differences in association of glycosylated hemoglobin levels with the prevalence of cardiovascular diseases among nondiabetics: the National Health and Nutrition Examination Survey 2005–2018
    Ruihan Fan, Li, Shuna, Xue, Zihan, Ruida Yang, Lyu, Jun, He, Hairong · 2024 · Figshare
  42. Additional file 1 of Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: a randomized dietary intervention pilot trial
    Michal Rein, Orly Ben-Yacov, Anastasia Godneva, Smadar Shilo, Niv Zmora, Dmitry S. Kolobkov, Noa Cohen-Dolev, Wolf, Bat-Chen, Noa Kosower, Maya Lotan‐Pompan et al. · 2022 · Figshare
  43. Additional file 3 of Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: a randomized dietary intervention pilot trial
    Michal Rein, Orly Ben-Yacov, Anastasia Godneva, Smadar Shilo, Niv Zmora, Dmitry S. Kolobkov, Noa Cohen-Dolev, Wolf, Bat-Chen, Noa Kosower, Maya Lotan‐Pompan et al. · 2022 · Figshare
  44. Bayesian cross-individual transfer learning for optimising predictive ratio CUSUM monitoring scheme
    Ziwei Chen, Jiao Yu, Chunjie Wu, Fugee Tsung · 2025 · International Journal of Production Research
  45. Letter: Response to: “Lack of Association Between Hemoglobin A1c and Continuous Glucose Monitor Metrics Among Individuals with Prediabetes and Normoglycemia”
    Simon Lebech Cichosz · 2025 · Diabetes Technology & Therapeutics
  46. Development of the health economic model for type 2 diabetes considering glycaemic variability
    Zhuoqi Gu, Lei Chen, Kexin Zhan, Xiaoyu Xi, Jing Wang · 2026 · Diabetes Obesity and Metabolism
  47. Time in range and its association with sudomotor dysfunction in individuals with type 1 diabetes mellitus
    Ismael A. Quintal-Medina, Rossy S. López-Prieto, Karen A. Romero-Torres, Ana Cristina García-Ulloa, Francisco Javier Gomez-Perez, Paloma Almeda‐Valdés · 2026 · Endocrinología Diabetes y Nutrición
  48. Glycemic management in adults with type 1 diabetes
    Chrysi C. Koliaki, Stavros Liatis · 2026 · Elsevier eBooks
  49. Glycated hemoglobin and dynapenia in community- dwelling older people with and without diabetes: A cross-sectional study
    André Luiz da Silva, Daniela Braga Lima, Gustavo Andrade Brancaglion, Guilherme Eustáquio Furtado, Ligiana Pires Corona, Tábatta Renata Pereira de Brito · 2026 · Journal of Diabetes & Metabolic Disorders
  50. Associations between the surrogate markers of insulin resistance and the mean blood glucose fluctuation amplitude in type 2 diabetic patients with different BMIs
    Zhai Ll, Nan Chen, Yue Wang, Tianrong Pan · 2026 · European journal of medical research
  51. Impact de la modulation de la digestibilité de l’amidon sur la variabilité et le contrôle glycémiques dans la prise en charge du diabète de type 2
    Anne-Esther Breyton · 2020 · theses.fr (ABES)
  52. Continuous glucose monitoring-based evaluation of percentage coefficient of variation (%CV) as a metric of intraday glycemic variability in South India
    Mohammed Azhar Hussain, Anil Kumar H., Mahadevamma Lingaiah · 2026 · Scientific Reports
  53. The Current Role and Clinical Impact of Continuous Glucose Monitoring on Canadian Adults Living With Type 2 Diabetes
    Jeremy Gilbert, Sonja M. Reichert, Tammy Cadieux, Peter Alexander Senior · 2026 · Canadian Journal of Diabetes
  54. Intermittent Use of Flash Glucose Monitoring as a Useful Tool for Patients with Type 1 Diabetes in Developing Countries
    Basma Z. Elmorsy, Hossam Arafa Ghazi, Amira S. Nowara, Hanan Abdelhay Elsherbiny · 2026 · International Journal of Diabetes and Technology
  55. Clinical and socioeconomic determinants of glycaemic control derived from continuous glucose monitoring in adults with type 1 diabetes
    Ángel Manuel Mesa Díaz, Pablo Rodríguez de Vera Gómez, María Ruíz Rodríguez, Samuel Belmonte Lomas, Blanca Gómez Zaragoza, Eduardo Mayoral Sánchez, María Asunción Martínez Brocca · 2026 · Frontiers in Endocrinology
  56. Trans-ethnic estimation and implications of genetic impact on continuous glycemic profiles
    Evan Yi-Wen Yu, Hui-Ying Ren, Xinxiu Liang, Yue Xi, Menglei Shuai, Zelei Miao, Fengzhe Xu, Ke Zhang, Luqi Shen, Hui Xia et al. · 2026 · Cell Discovery
  57. Time in range and its association with sudomotor dysfunction in individuals with type 1 diabetes mellitus
    Ismael A. Quintal-Medina, Rossy S. López-Prieto, Karen A. Romero-Torres, Ana Cristina García-Ulloa, Francisco Javier Gomez-Perez, Paloma Almeda‐Valdés · 2026 · Endocrinología Diabetes y Nutrición (English ed )
  58. Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes
    Tianyu Cao, Michael Fang, Amelia S. Wallace, Natalie Daya Malek, Arielle Valint, Dan Wang, Justin Basile Echouffo-Tcheugui, Scott L. Zeger, Elizabeth Selvin · 2026 · Clinical Chemistry
  59. Sustained reductions in hyperglycemia using a diabetes app with connected glucose meters in people with type 2 diabetes at higher risk for complications
    Mike Grady, Stephen MacKintosh, Matthew Fryett, Elizabeth Holt · 2026 · Exploration of Endocrine and Metabolic Diseases
  60. What Makes the Difference? Predicting Glycemic Trajectories Following Initiation of Automated Insulin Delivery Systems in Youth With Type 1 Diabetes
    JAYDE T. HOOVEN-DAVIS, Christina M. Lalama, SARAH A. SYER, Scott D. Rothenberger, Ingrid M. Libman, Christine A. March · 2026 · Diabetes Care
  61. Continuous Glucose Monitoring in Older‐Old With Type 2 Diabetes Mellitus: A Narrative Review of Evidence and Recommendations
    Patrice Darmon, Anne‐Sophie Boureau, Bernard Bauduceau, Judith Charbit, Benjamin Bouillet, Kamel Mohammedi, Bruno Guerci, Olivier Hanon · 2026 · Diabetes Obesity and Metabolism
  62. Association of glycation gap with hypoglycemia CGM indices, diabetic complications, and quality of life in Japanese type 2 diabetes patients
    Satomi Sonoda, Yosuke Okada, Tomoya Mita, Keiichi Torimoto, Kenichi Tanaka, Fumiya Sato, Naoto Katakami, Hidenori Yoshii, Keiko Nishida, Shingo Nakayamada et al. · 2026 · Journal of Diabetes Investigation
  63. AI in Diabetes Management: Neural Architecture Search for Blood Glucose Prediction
    Aritra Ray, Peter Domanski, Farshad Firouzi, Dirk Pflüger, Krishnendu Chakrabarty · 2025 · Springer eBooks
  64. High blood glucose index stratifies glycaemic severity and identifies occult type 2 diabetes risk in prediabetes via single‐day continuous glucose monitoring: A multi‐cohort study
    Weiming Wu, Shihan Wang, Junxiang Gao, Shuoning Song, Yating Zhang, Yong Fu, Mengmeng Zhang, Tao Yuan, Weigang Zhao · 2026 · Diabetic Medicine
  65. Comparative effectiveness of pioglitazone and sitagliptin added to metformin and sulfonylurea in patients with type 2 diabetes
    Tae Hyeon Kim, Yerin Hwang, Selin Woo, Kyeongmin Lee, Yejun Son, Seoyoung Park, Hyunjee Kim, Ju‐Young Shin, YongHyun Cho, Dahye Shin et al. · 2026 · Medicine
  66. Glycemic and safety outcomes of the insulin-only bionic pancreas in older adults and individuals with impaired awareness of Hypoglycemia: a post hoc analysis of a randomized pivotal trial
    Puguh Oktavian, Citrawati Dyah Kencono Wungu, Indah Mohd Amin, Sony Wibisono Mudjanarko · 2026 · Diabetes Research and Clinical Practice
  67. Interpretation of CGM and Insulin Pump Downloads
    David John McDonnell, Diarmuid Smith, Hannah Elizabeth Forde · 2026 · Springer eBooks
  68. Glucose Dispersion Is Associated With Contrast Sensitivity Beyond Average Glycemia
    Ren Zhang · 2026 · medRxiv
  69. Effects of short-bout accumulated physical activity and sedentary-break interventions on continuous glucose monitoring metrics in adults with type 2 diabetes: A systematic review and meta-analysis
    Sicheng Cao, Haozhe Wang, Yongliang Zhu, Changkun Shan, Wenjia Chen · 2026 · Frontiers in Endocrinology
  70. Research progress in microneedle-based electrochemical sensing for health monitoring
    Yumeng Zhao, Xin Cheng, Zheyuan Fan, Linshuang Mu, Haotian Li, Shaohua Song, Zhanhong Li, Itthipon Jeerapan, Zhigang Zhu · 2026 · Biomedical Instrumentation
  71. The management of type 1 diabetes in adults. The updated 2026 consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    Richard I. G. Holt, J. Hans DeVries, Amy Hess Fischl, Irl B. Hirsch, Marian Sue Kirkman, Tomasz Klupa, Barbara Ludwig, Kirsten Nørgaard, Jeremy Pettus, Éric Renard et al. · 2026 · Diabetologia
  72. Association Between Continuous Glucose Monitoring–Derived Time in Range and Diabetic Kidney Disease: A Systematic Review and Meta-Analysis of current evidence
    Siddharth Manish Lodha, S. Kumar, Shubho Acharya, Parth Dhamelia, Sandeep Garg · 2026 · medRxiv
  73. Remission or Reprieve? The Three Clocks of Type 2 Diabetes Remission
    Vivek Jha, Sanjay Kumar Bhadada · 2026 · Endocrine Practice
  74. Empirical transition probability modeling of continuous glucose monitoring data
    Yuanzhi Yu, Margaret M. Banker, Jennifer Sherr, Denise M. Scholtens · 2026 · PLoS ONE
  75. Evolution of risk management in diabetes mellitus: from standardized restrictions to personalized technological solutions
    S. J. Qosimova · 2026 · Health care of Tajikistan
  76. The Role of Hemoglobin A1C in the Era of Continuous Glucose Monitoring
    Jordan E. Perlman · 2026 · Endocrinology and Metabolism Clinics of North America
  77. National Trends and Predictors of Adverse Outcomes in Hypoglycemia Hospitalizations in the United States, 2017–2022
    Abu Huraira Bin Gulzar, Sheraz Hakeem, Muhammad Umer Sohail, Aima Tahir, Tamseer Tariq, Rasheeda Shehroz, Moiz Shah Khan, Ismail Rahim, Umme Aiman, Muhammad Afnan Ashraf et al. · 2026 · Endocrinology Diabetes & Metabolism
  78. Clinical Impact of Continuous Glucose Monitoring for 6–12 Months in Individuals with Type 2 Diabetes – A Retrospective, Chart-review Study from India
    Jothydev Kesavadev, Jaikishan Agrawal, Arun Shankar, Banshi Saboo · 2026 · International Journal of Diabetes and Technology